trending Market Intelligence /marketintelligence/en/news-insights/trending/yuliti1x7ryaulx9gva0ga2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

PAVmed seeks US FDA approval for drug delivery technology

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry

Cable Nets Struggle With Little Revenue Growth Expanding Programming Budgets


PAVmed seeks US FDA approval for drug delivery technology

PAVmed Inc. filed a 510(k) premarket notification submission with the U.S. FDA for its PortIO Intraosseous Infusion System.

The system consists of an implantable vascular access device and insertion kit that allows direct access to the bone marrow for the delivery of medications.